Related Experiment Video

Updated: Jul 2, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Integration of B-type natriuretic Peptide in heart failure outpatient programs

Ulf Dahlström1, Ken McDonald, Alan Maisel

  • 1Department of Cardiology, Heart Centre, Linköping University Hospital, Linköping, Sweden. ulf.dahlstrom@lio.se

Congestive Heart Failure (Greenwich, Conn.)
|October 4, 2008
PubMed

Insights

Natriuretic peptide (NP) assessment is crucial for diagnosing and managing heart failure (HF). Integrating NP testing into HF programs improves patient survival, reduces hospitalizations, and enhances quality of life.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Biomarkers

Background:

  • Heart failure (HF) management in Europe relies on specialized programs involving cardiologists and nurses.
  • Effective HF care aims to improve survival, reduce hospitalizations, and enhance patient quality of life.

Purpose of the Study:

  • To discuss the integration of natriuretic peptide (NP) assessment into heart failure (HF) outpatient programs.
  • To highlight the role of NPs in diagnosis, risk stratification, and tailored treatment for HF patients.

Main Methods:

  • Review of current practices in European HF management programs.
  • Exemplification of how NP assessment can be incorporated into outpatient HF care.

Main Results:

  • Natriuretic peptides (NPs) aid referring physicians in accurate HF diagnosis and patient selection.
  • NP levels enable effective risk stratification and personalized treatment strategies.
  • NP assessment is a valuable tool for optimizing HF patient management.

Conclusions:

  • NP values are essential and indispensable tools in the routine management of heart failure patients.
  • Integrating NP assessment into HF outpatient programs leads to improved clinical outcomes.
  • Continued utilization of NP testing is recommended for comprehensive HF care.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...